Mometason Hexal (Mometasone Furoate)

Mometasone Furoate, the active ingredient in Mometason Hexal, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis, including seasonal and perennial forms, in patients requiring local anti‑inflammatory therapy.

GNH USA supplies Mometason Hexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometason Hexal is a nasal corticosteroid that reduces inflammation in the nasal mucosa associated with allergic rhinitis. - Allergic rhinitis: relieves nasal congestion, sneezing, itching and rhinorrhea. - Seasonal allergic rhinitis: controls symptoms triggered by pollen exposure. - Perennial allergic rhinitis: manages year‑round nasal inflammation.

Mometason Hexal may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation. - Epistaxis (nosebleeds). - Headache. - Throat irritation or dryness. - Cough. - Altered taste perception.

Serious or Rare Side Effects: - Nasal septum perforation. - Severe allergic reaction (anaphylaxis). - Vision changes or ocular pressure increase. - Adrenal suppression with prolonged high‑dose use. - Opportunistic fungal infection of the nasal passages.

Before using Mometason Hexal, consider the following precautions. - Pregnancy: consult a healthcare provider; safety not fully established. - Elderly: monitor for increased local adverse effects. - Recent nasal surgery: postpone use until the surgical site has healed. - Concomitant systemic corticosteroids: risk of additive glucocorticoid effects. - Known hypersensitivity to mometasone or formulation components: avoid use. - Store at room temperature: keep in the original container, protect from moisture and heat.

Mometason Hexal can interact with other medicines; review the following.

Major Interactions (Avoid): - Systemic corticosteroids: may increase overall glucocorticoid exposure. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug levels. - Live vaccines: potential for reduced vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antihistamines: may provide additive symptom relief. - Decongestant nasal sprays: increased risk of nasal irritation. - Antifungal nasal preparations: may affect local microbial balance.